We are live on ! Find out more
GILD icon

Gilead Sciences

2,024 hedge funds and large institutions have $119B invested in Gilead Sciences in 2025 Q2 according to their latest regulatory filings, with 188 funds opening new positions, 840 increasing their positions, 734 reducing their positions, and 152 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $1.41B | Put options by funds: $1.06B

24% more first-time investments, than exits

New positions opened: 188 | Existing positions closed: 152

14% more repeat investments, than reductions

Existing positions increased: 840 | Existing positions reduced: 734

0.92% more ownership

Funds ownership: 85.5%86.42% (+0.92%)

0% more funds holding

Funds holding: 2,0142,024 (+10)

0% less capital invested

Capital invested by funds: $119B → $119B (-$143M)

37% less funds holding in top 10

Funds holding in top 10: 5233 (-19)

Holders
2,024
Holders Change
+10
Holders Change %
+0.5%
% of All Funds
26.65%
Holding in Top 10
33
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-36.54%
% of All Funds
0.43%
New
188
Increased
840
Reduced
734
Closed
152
Calls
$1.41B
Puts
$1.06B
Net Calls
+$356M
Net Calls Change
+$352M
Name Holding Trade Value Shares
Change
Change in
Stake
CB
776
Cadence Bank
Mississippi
$1.94M +$982K +9,225 +112%
PWG
777
Portside Wealth Group
Utah
$1.94M +$66.1K +621 +4%
CCM
778
Cinctive Capital Management
New York
$1.93M +$449K +4,218 +32%
SWP
779
Sagespring Wealth Partners
Tennessee
$1.92M +$410K +3,848 +28%
PWS
780
Precision Wealth Strategies
Missouri
$1.92M +$1.84M +17,327 New
IFG
781
Independent Financial Group
California
$1.91M +$496K +4,661 +37%
BJL
782
Brighton Jones LLC
Washington
$1.91M +$235K +2,208 +15%
FFM
783
Forum Financial Management
Illinois
$1.91M +$639 +6 +0%
BFO
784
Boston Family Office
Massachusetts
$1.91M
SCA
785
Snowden Capital Advisors
New York
$1.91M -$300K -2,817 -14%
FIM
786
Freedom Investment Management
Connecticut
$1.91M -$183K -1,721 -9%
MNBTD
787
Moody National Bank Trust Division
Texas
$1.91M +$104K +976 +6%
ET
788
Equitable Trust
Tennessee
$1.9M -$31.1K -292 -2%
IHL
789
Investment House LLC
California
$1.89M -$243K -2,280 -12%
LSA
790
Leonteq Securities AG
Switzerland
$1.87M +$357K +3,359 +25%
AMBIA
791
Allen Mooney & Barnes Investment Advisors
Georgia
$1.84M +$426 +4 +0%
Walleye Capital
792
Walleye Capital
New York
$1.84M +$1.76M +16,584 New
EGA
793
E&G Advisors
Texas
$1.84M -$87.4K -821 -5%
SQA
794
Simon Quick Advisors
New Jersey
$1.84M +$824K +7,746 +88%
SLI
795
Sumitomo Life Insurance
Japan
$1.79M -$107K -1,006 -6%
AFCM
796
Applied Finance Capital Management
Puerto Rico
$1.78M -$699K -6,564 -29%
TS
797
Triglav Skladi
Slovenia
$1.77M
FWCM
798
Ferguson Wellman Capital Management
Oregon
$1.77M +$291K +2,730 +21%
CAG
799
Crestwood Advisors Group
Massachusetts
$1.76M +$102K +955 +6%
PWAM
800
Papamarkou Wellner Asset Management
New York
$1.75M -$34.6K -325 -2%

GILD Hedge Fund Activity: Q2 2025 in Review

2,024 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2025, worth a combined $119B — down 0.12% from $119B a quarter earlier.

Buyers outnumbered sellers: 188 funds opened new GILD positions and 152 closed out — a net gain of 36 holders — while 840 added to existing stakes and 734 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $1.08B. The largest seller was Capital Research Global Investors, cutting an estimated $2.5B.

  • 2,024 institutional investors held Gilead Sciences (GILD) as of Q2 2025, up from 2,014 in Q1 2025.
  • Funds reported $119B of Gilead Sciences stock for Q2 2025, down 0.12% quarter-over-quarter.
  • 188 funds opened new Gilead Sciences positions in Q2 2025 and 152 closed out, a net change of +36 holders.
  • The largest Gilead Sciences buyer in Q2 2025 was Wellington Management Group, an estimated $1.08B added.
  • The largest Gilead Sciences seller in Q2 2025 was Capital Research Global Investors, an estimated $2.5B sold.

Based on aggregated 13F filings for Q2 2025.